"If you ve possibly been exposed to the coronavirus (COVID-19) and are experiencing symptoms, we recommend that your first contact with a health care provider be through telemedicine. Houston Methodist Virtual Urgent Care is available 24/7- no appointment necessary. Or, if you re planning an in-person visit, please call ahead to inform your healthcare provider."

During the past decade, Houston Methodist Neurological Institute/Movement Disorders Clinic (135) conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Houston Methodist Neurological Institute/Movement Disorders Clinic (135)" #1 collaborator was "Acorda Therapeutics" with 1 trials as a collaborator, "Massachusetts General Hospital" with 1 trials as a collaborator and "Michael J. Fox Foundation for Parkinson's Research" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Houston Methodist Neurological Institute/Movement Disorders Clinic (135)" are "ALS" (1 trials), "Amyotrophic Lateral Sclerosis" (1 trials), "Parkinson Disease" (1 trials), "Parkinson's Disease (Disorder)" (1 trials) and "Parkinson's Disease Dementia (PDD)" (1 trials). Many other conditions were trialed in "Houston Methodist Neurological Institute/Movement Disorders Clinic (135)" in a lesser frequency.

Most popular intervention types in "Houston Methodist Neurological Institute/Movement Disorders Clinic (135)" are "Drug" (4 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "IPX203 140 mg" (1 trials), "IPX203 210 mg" (1 trials), "IPX203 280 mg" (1 trials) and "IPX203 350 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Houston Methodist Neurological Institute/Movement Disorders Clinic (135)" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Houston Methodist Neurological Institute/Movement Disorders Clinic (135)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Houston Methodist Neurological Institute/Movement Disorders Clinic (135), undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Houston Methodist Neurological Institute/Movement Disorders Clinic (135), 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".